Acer Therapeutics
(NASDAQ) ACER
This security has been delisted. This page is retained for historical reference.
ACER News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowACER Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
283.88%
Return on Capital
N/A
Return on Assets
-225.71%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$287.99K
Operating Income
-$27.42M
EBITDA
-$41.49M
Operating Cash Flow
-$38.82M
Capital Expenditure
-$138.40K
Free Cash Flow
-$38.95M
Cash & ST Invst.
$594.66K
Total Debt
$18.15M
Acer Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$371.79K
N/A
Gross Profit
$287.99K
N/A
Gross Margin
77.46%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
30
N/A
Net Income
-$14.73M
-195.3%
EBITDA
-$14.86M
-198.8%
Quarterly Fundamentals
Total Cash
$594.66K
-90.7%
Total Debt
$18.15M
+120.1%
Accounts Receivable
$0.00
N/A
Inventory
$5.20M
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$18.15M
+1101.7%
Return on Assets
-2.26%
N/A
Return on Invested Capital
3.36%
N/A
Free Cash Flow
-$16.00M
-75.9%
Operating Cash Flow
-$16.00M
-76.0%